{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:19:26Z","timestamp":1793657966755,"version":"4.5.1"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Although heart transplantation is the definitive treatment for heart failure in eligible patients, both acute and chronic transplant rejection frequently occur. Protein phosphatase 2A (PP2A) activity is critical in maintaining tissue and organ homeostasis. In this study, we evaluated the effect of a novel class of small molecule activators of PP2A (SMAPs) on allograft rejection in a mouse heterotopic heart transplantation model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Recipient mice were administered with DT-061 (a pharmaceutically optimized SMAP) or vehicle by oral gavage beginning 1 d after transplantation. Histological and immunofluorescence analyses were performed to examine allograft rejection. Regulatory T cells (Treg) from recipient spleens were subjected to flow cytometry and RNA sequencing analysis. Finally, the effect of DT-061 on smooth muscle cells (SMCs) migration and proliferation was assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>DT-061 treatment prolonged cardiac allograft survival. SMAPs effectively suppressed the inflammatory immune response while increasing Treg population in the allografts, findings corroborated by functional analysis of RNA sequencing data derived from Treg of treated splenic tissues. Importantly, SMAPs extended immunosuppressive agent cytotoxic T lymphocyte\u2013associated antigen-4-Ig\u2013induced cardiac transplantation tolerance and allograft survival. SMAPs also strongly mitigated cardiac allograft vasculopathy as evidenced by a marked reduction of neointimal hyperplasia and SMC proliferation. Finally, our in vitro studies implicate suppression of MEK\/ERK pathways as a unifying mechanism for the effect of PP2A modulation in Treg and SMCs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>PP2A activation prevents cardiac rejection and prolongs allograft survival in a murine model. Our findings highlight the potential of PP2A activation in improving alloengraftment in heart transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004832","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T20:08:18Z","timestamp":1697486898000},"page":"e36-e48","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Protein Phosphatase 2A Activation Promotes Heart Transplant Acceptance in Mice"],"prefix":"10.1097","volume":"108","author":[{"given":"Xianming","family":"Zhou","sequence":"first","affiliation":[{"name":"Cardiology Division, Department of Medicine, Emory University School of Medicine, Atlanta, GA."},{"name":"Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Medicine, Emory University School of Medicine, Atlanta, GA."},{"name":"Department of Cardiovascular Surgery, Xiangya Hospital of Central South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianguo","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Stomberski","sequence":"additional","affiliation":[{"name":"Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham","family":"Narla","sequence":"additional","affiliation":[{"name":"Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Lin","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Medicine, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4070\/kcj.2018.0189","article-title":"The past, present and future of heart transplantation.","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Eighth Adult Lung Transplantation Report\u20142021; focus on recipient characteristics.","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report\u20142018; focus theme: multiorgan transplantation.","volume":"37","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.surge.2010.11.023","article-title":"Cardiac allograft rejection.","volume":"9","author":"Patel","year":"2011","journal-title":"Surgeon"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation.","volume":"25","author":"Ingulli","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.CIR.96.6.2069","article-title":"Cardiac allograft vasculopathy: a review.","volume":"96","author":"Weis","year":"1997","journal-title":"Circulation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"794089","DOI":"10.4061\/2011\/794089","article-title":"Regulation and function of protein kinases and phosphatases.","volume":"2011","author":"Cheng","year":"2011","journal-title":"Enzyme Res"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure.","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2007.06.034","article-title":"PP2A: unveiling a reluctant tumor suppressor.","volume":"130","author":"Mumby","year":"2007","journal-title":"Cell"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","article-title":"Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease.","volume":"7","author":"Sontag","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1172\/JCI24895","article-title":"Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.","volume":"115","author":"Katsiari","year":"2005","journal-title":"J Clin Invest"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12988","article-title":"In vivo discovery of immunotherapy targets in the tumour microenvironment.","volume":"506","author":"Zhou","year":"2014","journal-title":"Nature"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2014.01.015","article-title":"Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.","volume":"40","author":"Long","year":"2014","journal-title":"Immunity"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ni.3390","article-title":"Phosphatase PP2A is requisite for the function of regulatory T cells.","volume":"17","author":"Apostolidis","year":"2016","journal-title":"Nat Immunol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.03.038","article-title":"Selective PP2A enhancement through biased heterotrimer stabilization.","volume":"181","author":"Leonard","year":"2020","journal-title":"Cell"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI89548","article-title":"Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.","volume":"127","author":"Sangodkar","year":"2017","journal-title":"J Clin Invest"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/0008-5472.CAN-17-0123","article-title":"Small-molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer.","volume":"78","author":"McClinch","year":"2018","journal-title":"Cancer Res"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"e125693","DOI":"10.1172\/jci.insight.125693","article-title":"Direct activation of PP2A for the treatment of tyrosine kinase inhibitor-resistant lung adenocarcinoma.","volume":"4","author":"Tohme","year":"2019","journal-title":"JCI Insight"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/0008-5472.CAN-18-0717","article-title":"Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma.","volume":"79","author":"Allen-Petersen","year":"2019","journal-title":"Cancer Res"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0021-9258(17)49933-9","article-title":"Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.","volume":"295","author":"Farrington","year":"2020","journal-title":"J Biol Chem"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yjmcc.2016.11.003","article-title":"Roles and regulation of protein phosphatase 2A (PP2A) in the heart.","volume":"101","author":"Lubbers","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"110213","DOI":"10.1016\/j.cellsig.2021.110213","article-title":"Protein phosphatase 2A in the healthy and failing heart: new insights and therapeutic opportunities.","volume":"91","author":"Sergienko","year":"2022","journal-title":"Cell Signal"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1042\/CS20210315","article-title":"Allosteric activation of PP2A inhibits experimental abdominal aortic aneurysm.","volume":"135","author":"Zhou","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nprot.2007.48","article-title":"Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy.","volume":"2","author":"Hasegawa","year":"2007","journal-title":"Nat Protoc"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ajt.14543","article-title":"Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.","volume":"18","author":"Zhao","year":"2018","journal-title":"Am J Transplant"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"12788","DOI":"10.1073\/pnas.1513533112","article-title":"CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.","volume":"112","author":"Harper","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2567.1997.00187.x","article-title":"Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor V beta genes.","volume":"90","author":"Shirwan","year":"1997","journal-title":"Immunology"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.healun.2008.01.004","article-title":"Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.","volume":"27","author":"Kitazawa","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/ajt.13872","article-title":"The immunosuppressive effect of CTLA4 immunoglobulin is dependent on regulatory T cells at low but not high doses.","volume":"16","author":"Schwarz","year":"2016","journal-title":"Am J Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.transproceed.2008.03.148","article-title":"Mechanisms of survival prolongation of murine cardiac allografts using the treatment of CTLA4-Ig and MR1.","volume":"40","author":"Zhu","year":"2008","journal-title":"Transplant Proc"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3389\/fimmu.2017.01169","article-title":"Successful treatment of T cell-mediated acute rejection with delayed CTLA4-Ig in mice.","volume":"8","author":"Young","year":"2017","journal-title":"Front Immunol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.4049\/jimmunol.162.8.4983","article-title":"CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.","volume":"162","author":"Zheng","year":"1999","journal-title":"J Immunol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00007890-199457120-00002","article-title":"Transplantation tolerance induced by CTLA4-Ig.","volume":"57","author":"Pearson","year":"1994","journal-title":"Transplantation"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year safety and efficacy of belatacept in renal transplantation.","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis.","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"R40-20250604","first-page":"2624","article-title":"Cardiac allograft vasculopathy: current review and future research directions.","volume":"117","author":"Pober","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"608747","DOI":"10.3389\/fcell.2020.608747","article-title":"Modulation of TCR signaling by tyrosine phosphatases: from autoimmunity to immunotherapy.","volume":"8","author":"Castro-Sanchez","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein tyrosine phosphatases as potential therapeutic targets.","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2020.03.051","article-title":"Allosteric activators of protein phosphatase 2A display broad antitumor activity mediated by dephosphorylation of MYBL2.","volume":"181","author":"Morita","year":"2020","journal-title":"Cell"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.bmc.2015.07.007","article-title":"Reengineered tricyclic anti-cancer agents.","volume":"23","author":"Kastrinsky","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cell.2020.04.005","article-title":"Piecing together a broken tumor suppressor phosphatase for cancer therapy.","volume":"181","author":"Westermarck","year":"2020","journal-title":"Cell"},{"key":"R46-20250604","first-page":"1","article-title":"PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart.","volume":"50","author":"Yoon","year":"2018","journal-title":"Exp Mol Med"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCRESAHA.121.319519","article-title":"Renal AT(2) receptors mediate natriuresis via protein phosphatase PP2A.","volume":"130","author":"Kemp","year":"2022","journal-title":"Circ Res"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00007890-199106000-00001","article-title":"Cells mediating allograft rejection.","volume":"51","author":"Hall","year":"1991","journal-title":"Transplantation"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/eci.09.64","article-title":"Role of T cells in graft rejection and transplantation tolerance.","volume":"6","author":"Issa","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMra055446","article-title":"Regulation of immune responses by T cells.","volume":"354","author":"Jiang","year":"2006","journal-title":"N Engl J Med"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.it.2004.12.007","article-title":"Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells.","volume":"26","author":"Graca","year":"2005","journal-title":"Trends Immunol"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/emboj.2010.331","article-title":"Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation.","volume":"30","author":"Eitelhuber","year":"2011","journal-title":"EMBO J"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.4049\/jimmunol.2001266","article-title":"The regulatory subunit PPP2R2A of PP2A enhances Th1 and Th17 differentiation through activation of the GEF-H1\/RhoA\/ROCK signaling pathway.","volume":"206","author":"Pan","year":"2021","journal-title":"J Immunol"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1073\/pnas.1807484116","article-title":"Phosphatase PP2A is essential for TH17 differentiation.","volume":"116","author":"Xu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.mib.2008.05.015","article-title":"Tumor necrosis factor and interferon: cytokines in harmony.","volume":"11","author":"Bartee","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00007890-199308000-00029","article-title":"Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection.","volume":"56","author":"Pizarro","year":"1993","journal-title":"Transplantation"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"e139687","DOI":"10.1172\/jci.insight.139687","article-title":"Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection.","volume":"6","author":"Payne","year":"2021","journal-title":"JCI Insight"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/imt.10.33","article-title":"TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.","volume":"2","author":"Booth","year":"2010","journal-title":"Immunotherapy"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","article-title":"Transforming growth factor-beta signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses.","volume":"46","author":"Konkel","year":"2017","journal-title":"Immunity"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling.","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling.","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/eji.201242889","article-title":"ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis.","volume":"43","author":"Liu","year":"2013","journal-title":"Eur J Immunol"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ni.3076","article-title":"Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses.","volume":"16","author":"Shrestha","year":"2015","journal-title":"Nat Immunol"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2017.07.012","article-title":"The serine\/threonine protein phosphatase 2A controls autoimmunity.","volume":"186","author":"Sharabi","year":"2018","journal-title":"Clin Immunol"},{"key":"R66-20250604","first-page":"395","article-title":"Mechanisms of chronic cardiac allograft rejection.","volume":"40","author":"Costello","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bpa.2017.06.003","article-title":"Long-term outcomes and management of the heart transplant recipient.","volume":"31","author":"McCartney","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R68-20250604","first-page":"9376662","article-title":"Frequency-modulated continuous wave radar respiratory pattern detection technology based on multifeature.","volume":"2021","author":"Wang","year":"2021","journal-title":"J Healthc Eng"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Adult Heart Transplantation Report\u20142019; focus theme: donor and recipient size match.","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(00)80366-0","article-title":"The emerging role of CTLA-4 as an immune attenuator.","volume":"7","author":"Thompson","year":"1997","journal-title":"Immunity"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1600-6143.2011.03624.x","article-title":"Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner.","volume":"11","author":"Zhang","year":"2011","journal-title":"Am J Transplant"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.4049\/jimmunol.171.11.5673","article-title":"Cutting edge: transplantation tolerance through enhanced CTLA-4 expression.","volume":"171","author":"Ariyan","year":"2003","journal-title":"J Immunol"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1600-6143.2009.02578.x","article-title":"Preferential priming of alloreactive T cells with indirect reactivity.","volume":"9","author":"Brennan","year":"2009","journal-title":"Am J Transplant"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/phar.2716","article-title":"Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation.","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacotherapy"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/10409238.2016.1143913","article-title":"PP2A as a master regulator of the cell cycle.","volume":"51","author":"Wlodarchak","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:06:00Z","timestamp":1749060360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004832","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}